As scientists continue to learn more about the potential causes behind Alzheimer’s disease, some recent research has been focusing on looking for the earliest possible warning signs for this type of dementia.
One tool that doctors are beginning to use to help predict a person’s Alzheimer’s disease risk in its earliest stages is through blood tests that search for specific biomarkers in the blood.
Now, a new study published in The Lancet, primarily funded by the National Institutes of Health (NIH), has found that these biomarker blood tests may also help doctors detect very early signs of cognitive decline in midlife adults without a dementia diagnosis.
Read Full Article Here
